pharmaphorum

OCTOBER 20, 2020

The pandemic has triggered a change in how pharmaceutical companies are engaging with healthcare professionals. When IQVIA polled non COVID-19 treating Italian HCPs in March when the crisis was at its worst, it asked HCPs if they still welcomed pharmaceutical company engagement during the crisis. The answer was yes.

Pharmaceutical Companies 122

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 122

PharmaState Academy

MARCH 12, 2023

Preamble Why this White Paper? A white paper (sometimes called as whitepaper) is an information document issued by an organization to highlight the solution to a problem the functionality of a solution, good, or service. In this white paper, we will explore the key principles of GMaP in the pharmaceutical industry.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Hospitals Communication 52

Pharmaceutical Technology

DECEMBER 9, 2022

Pharmaceutical sales in Brazil reached $17bn in 2021, according to GlobalData figures. Despite this, Brazil’s trade protectionist policies mean that there are few pharmaceutical companies of international origin within the country. by 2040 based on statistics from OECD. </p> By Tanner Pharma Group.

Drug Pricing 98

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 98

Pharma Marketing Network

JULY 21, 2023

The pharmaceutical industry is a highly regulated one, and as such, traditional marketing channels such as advertising can be limited. However, content marketing is a great way for pharmaceutical companies to reach their target audience and drive sales.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

APRIL 11, 2022

Pharmaceutical companies have said they will try to carve months off the time between approval and launch for new medicines in Europe, and reduce disparities between access between countries. — EFPIA (@EFPIA) April 11, 2022.

Documentation 52

Documentation Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

NOVEMBER 3, 2021

Committed to innovation, product excellence, and customer success, Veeva serves more than 1,100 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is the global leader in cloud software for the life sciences industry.

Compounding 98

Compounding Communication Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

MAY 13, 2021

Committed to innovation, product excellence, and customer success, Veeva serves more than 975 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is the global leader in cloud software for the life sciences industry.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

NOVEMBER 14, 2022

In order to incentivise innovative medicines, health technology assessment (HTA) bodies should consider evaluating the benefits that greener medicines bring to society and drive this change in the companies that are better capitalised to do so.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

FEBRUARY 17, 2023

However, Amgen and other pharmaceutical companies have been criticised when they opted to choose the drug’s dosage based on the MTD model, which is commonly used in dose-finding trials. Impact on the industry Veal says that for a lot of pharmaceutical companies there is no “big drive to think about optimizing treatment” post-licensing.

Dosage 115

Dosage Clinical Pharmacology Pharmaceutical Companies Pharmaceutical Companies 115

Pharmaceutical Technology

DECEMBER 19, 2022

This economic change impacts employment, income, industrial production, and more, and the pharmaceutical industry will not be exempt. While larger, more established pharmaceutical companies may have the infrastructure and financial cushion to fall back on, SMEs need to tread carefully through these economic challenges.

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Generic Medicine 69

pharmaphorum

OCTOBER 27, 2020

Given the recent rise in digital engagement and the drastic increase in digital content, it’s now essential that pharmaceutical companies have a comprehensive content strategy. This enables pharma companies to simplify management of digital assets and speed up the creation, and review of new promotional materials.

Pharmaceutical Companies 64

Pharmaceutical Companies Pharmaceutical Companies 64

pharmaphorum

JUNE 1, 2022

To help pharmaceutical companies reach patients broadly and get them engaged in meaningful actions to improve their health outcomes, this whitepaper analyses: How behavioural science can achieve lasting change.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

JANUARY 16, 2023

This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles.

Drug Pricing 64

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 64

Pharmaceutical Technology

MARCH 17, 2023

GlobalData calculates these risk scores by evaluating several qualitative and quantitative factors to establish the quality of conditions and the level of stability of the market access environment encountered by pharmaceutical companies in each country.

Communication 102

Communication Pharmaceutical Companies Pharmaceutical Companies 102

Pharmaceutical Technology

JANUARY 16, 2023

This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

European Pharmaceutical Review

DECEMBER 21, 2022

“As the contribution of costs of organic chemicals used as feedstock to the operating expenditures is small, the pharmaceutical companies can spearhead and guide the transition.” Design of a Continuous Solvent Recovery System for End-to-End Integrated Continuous Manufacturing of Pharmaceuticals. 199‒208.

Compounding 97

Compounding Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

Pharmaceutical Technology

FEBRUARY 3, 2023

These single-use technologies allow pharmaceutical companies to achieve continuous manufacturing, which significantly reduces the risk of cross-contamination without the need for extensive cleaning and disinfecting.

Dosage 52

Dosage Pharmaceutical Manufacturing Packaging Communication 52

Pharmaceutical Technology

FEBRUARY 28, 2023

For many years, the pharmaceutical industry has been accused of overlooking this patient population by instead targeting investments toward more prevalent indications. The stakes are high when launching an orphan drug product, however.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development Communication 52

Pharmaceutical Technology

FEBRUARY 28, 2023

Celnova Pharma is an Argentina-based pharmaceutical company that centres its work around rare diseases, oncology, central nervous system, diabetes and critical care. The company currently has operations in Argentina, Colombia, Chile, Peru, and Uruguay.

Communication 52

Communication Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 6, 2023

According to Baker Mackenzie , a law firm brand that specialises in a range of industries including healthcare and life sciences, IPOs allow pharmaceutical companies to “access major global finance hubs and capital from a deep pool of investors around the world”.

Communication 59

Communication Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

JUNE 11, 2025

Skip to main content Wednesday 11 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Diabetes 87

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 87

Pharmaceutical Technology

DECEMBER 15, 2022

One antimicrobial agent that pharmaceutical companies have turned to time and time again is Benzalkonium Chloride (BKC) – a well-known quaternary ammonium compound that has supported pharmaceutical formulations as far back as the 1940s. Is Benzalkonium Chloride a good choice?

Documentation 52

Documentation Compounding Communication Pharmaceutical Companies 52

Pharmaceutical Technology

DECEMBER 6, 2022

Explaining the rise of HPAPIs, Bruno Villa, CEO, MEDELPHARM believes the trend is a consequence of the increasing pressure on pharmaceutical companies to develop drugs with improved efficiency and efficacy. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology.

Drug Development 52

Drug Development Dosage Pharmaceutical Manufacturing Communication 52

Pharmaceutical Technology

DECEMBER 22, 2022

As pharmaceutical companies launch their products across European countries, the joint procedure is intended to reduce the duplication of submissions with different evidence requirements and procedural times required at a country level, and thus streamline workflows and reduce administrative burden.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling Communication 52

pharmaphorum

JUNE 6, 2025

Skip to main content Friday 6 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

Pharmaceutical Technology

FEBRUARY 9, 2023

This guidance has driven many pharmaceutical companies to revaluate their approach to CCIT. According to Lukas Engel, market manager pharma CCIT at Pfeiffer Vacuum, companies are increasingly looking to perform high throughput testing with sophisticated, deterministic methods.

Packaging 52

Packaging Pharmaceutical Manufacturing Communication Pharmaceutical Companies 52

pharmaphorum

JUNE 11, 2025

Skip to main content Wednesday 11 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Diabetes 92

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 92

Pharmaceutical Technology

FEBRUARY 7, 2023

Starting research early and using the findings to inform R&D decisions gives pharmaceutical companies the best chance of success when they come to scale the many market access obstacles presented by Europe. Overall, it is never too soon to begin market access activities, but it can easily be too late.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Inpatient Drug Pricing Packaging 52

Pharmaceutical Technology

MARCH 6, 2023

The CLR is a great option for pharmaceutical companies performing steam sterilisation in the drying chamber. The CLR is temperature controlled to 160°C, enabling the highest accuracy and protection against condensation. But that isn’t the only demanding application in the freeze drying world.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JANUARY 14, 2021

Not so China, and especially not so the lead five European countries – on average European pharmaceutical companies saw a loss of 30% of the interactive time they previously had with healthcare professionals in 2020. Up to November, the US and Japan actually saw increases in interactive time in 2020. Pharma pivots East.

Biosimilars 72

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Labelling 72

pharmaphorum

JUNE 6, 2025

Skip to main content Friday 6 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 59

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 59

Pharmaceutical Technology

MARCH 22, 2023

In the 1990s, generic pharmaceutical companies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. It was a money-saving strategy that was paying off until Covid-19 hit.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Packaging Communication Diabetes 105

Pharmaceutical Technology

MARCH 6, 2023

He goes on to say that this might incentivize more pharmaceutical companies to develop drugs that target the biology of aging. The incentive from the FDA’s perspective would be the possible larger effect size on multiple age-related diseases compared to that of drugs currently being developed,” he says.

Labelling 145

Labelling Communication Diabetes Pharmaceutical Companies 145

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

Eye on FDA

NOVEMBER 18, 2021

Media coverage regarding the nomination has been largely focused on concerns expressed by some about Dr. Califf’s past work with pharmaceutical companies in clinical research. Though, of course, it is a very different political climate and a different Senate than it was the first time.

Communication 57

Communication Pharmaceutical Companies Pharmaceutical Companies 57

pharmaphorum

JUNE 29, 2022

She has an extremely wide experience of international pharmaceutical industry issues, consulting to the world’s leading pharmaceutical companies on global issues. She has been vice resident, European Marketing and Thought Leadership in IQVIA for 12 years. the impact of the pandemic on medicines markets and Rx launch.

HIV Treatment and Prevention Agents 59

HIV Treatment and Prevention Agents Vaccines Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

MARCH 22, 2023

Large-molecule drugs such as biologics are particularly sensitive to foreign contamination and E&L interaction, making these issues key concerns for pharmaceutical companies. In addition, packaging components are not entirely manufactured in a clean room environment, making them a potential source of exogenous contamination.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52